Riitta Lassila

19PUBLICATIONS
57CO-AUTHORS
HaematologyEpidemiological modellingHaematological tumoursPredictive and prognostic markersCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 03, 2025
Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab: Results From the Phase IV HemiNorth 2 Study.

Jan Astermark, Susanna Ranta, Linda Myrin-Westesson

|Jun 21, 2025
Switching From Standard to Extended Half-Life Coagulation Factor Replacement in Haemophilia: Clinical Outcomes and Costs of Care in Finland.

Mirkka Koivusalo, Timea Szanto, Tuomas Kovalainen

|Apr 02, 2025
Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry.

Kathelijn Fischer, Riitta Lassila, Flora Peyvandi

|Feb 10, 2025
Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update.

Carmen Escuriola Ettingshausen, Riitta Lassila, Gines Escolar

|Dec 03, 2024
Venous thromboembolism treatment failure during use of factor Xa inhibitors-association with thoracic outlet syndrome and development of chronic thromboembolic pulmonary hypertension.

Matti Kaksonen, Piia Simonen, Riitta Lassila

|Jul 31, 2024
Prognostic role of the neutrophil/lymphocyte ratio in high-risk BCG-naïve non-muscle-invasive bladder cancer treated with intravesical gemcitabine/docetaxel.

Mohamad Abou Chakra, Riitta Lassila, Nancy El Beayni

Pageof 4

Frequent Collaborators

3 joint publications

Timea Szanto

3 joint publications

Erik Berntorp

3 joint publications

Jan Astermark

3 joint publications

Vuokko Nummi